Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI received FDA investigational device exemption (IDE) to conduct the study...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
vVARDIS has announced a strategic minority investment from funds managed by Apollo, a global alternative asset management firm. The investment will support the company’s...
US-based TaeWoong Medical has secured the US Food and Drug Administration (FDA) clearance to commercialise the Niti-S Spaxus Stent, expanding its range of endoscopic...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...
Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system.
Findings published in the Journal of Neurointerventional...
CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
vVARDIS has announced a strategic minority investment from funds managed by Apollo, a global alternative asset management firm. The investment will support the company’s...
US-based TaeWoong Medical has secured the US Food and Drug Administration (FDA) clearance to commercialise the Niti-S Spaxus Stent, expanding its range of endoscopic...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...